Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020

発現ベクターの世界市場:細菌発現ベクター、哺乳類発現ベクター、昆虫発現ベクター、酵母発現ベクター

◆タイトル:Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020
◆商品コード:MAM-BT-3493
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年6月16日
◆ページ数:138
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、発現ベクターの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、市場シェア分析、種類別分析、用途別分析、需要先別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。

The expression vectors market is expected to reach $317.1 million by 2020 from $242.7 million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. The market is categorized on the basis of host type, application, end user, and region. The application market includes therapeutic, research, and industrial applications. The therapeutic applications segment is expected to grow at the highest CAGR in the coming five years.

Major factors contributing to the growth of the global expression vectors market include increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. For instance, in September 2014, AbCelex Technologies Inc., a privately held Canadian biotechnology company, received a venture capital fund of $1 million by Pinetree Capital Corporation for development of the company’s protein expression systems and antibody engineering techniques. Funding for protein research helps the expression vectors market to grow as it is an integral component of it.

The Asian expression vectors market is the fastest-growing market, globally. With huge man power and cost-effective manufacturing facilities, several market players are focusing on expanding their presence in the Asian countries. For instance, in November 2012, Promega Corporation (U.S.), a provider of expression vectors, opened a new facility in Shanghai, Shanghai Promega Life Science Center. This facility manufactures biological and chemical regents and instruments used in life science research and molecular diagnostics. Establishment of such facilities helps the local market with easy product availability and services.

Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the expression vectors market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the expression vectors market. The report analyzes this market by host type, application, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the expression vectors market
• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the expression vectors market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various expression vector products across regions
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the expression vectors market

【レポートの目次】

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Years Considered for the Study
1.4 Limitations
1.5 Market Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Key Industry Insights
2.6 Assumptions for the Study

3 Executive Summary

4 Premium Insights

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Host Type
5.2.2 By Application
5.2.3 By End User
5.2.4 By Region
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increase in Demand of Protein-Based Drugs (Biologics)
5.3.1.2 High Prevalence Rate of Lifestyle Diseases, Infectious Diseases, and Genetic Disorders
5.3.1.3 Funding for Protein Research
5.3.2 Restraints
5.3.2.1 High Market Consolidation Increases Entry Barriers and Restrains Market Growth
5.3.2.2 High Cost of Protein Therapy
5.3.3 Opportunities
5.3.3.1 Developing Countries Present Significant Opportunities for Market
5.3.4 Challenges
5.3.4.1 Sequestration Cuts in the U.S.: Challenge to the North American Market

6 By Host Type
6.1 Introduction
6.2 Bacterial Expression Vectors
6.2.1 E.Coli Expression Vectors
6.2.2 Other Bacterial Expression Vectors
6.3 Mammalian Expression Vectors
6.3.1 CHO Expression Vectors
6.3.2 Other Mammalian Expression Vectors
6.4 Insect Expression Vectors
6.4.1 Baculovirus Expression Vectors
6.4.2 Other Insect Expression Vectors
6.5 Yeast Expression Vectors
6.5.1 K. Lactis Expression Vectors
6.5.2 Pichia Pastoris Expression Vectors
6.5.3 Saccharomyces Cerevisiae Expression Vectors
6.5.4 Other Yeast Expression Vectors
6.6 Other Expression Vectors

7 By Application
7.1 Introduction
7.2 Therapeutic Applications
7.3 Industrial Applications
7.4 Research Applications

8 By End User
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 CROS and CMOS
8.4 Academic Research Institutes
8.5 Other End Users

9 Geographic Analysis
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.5 Rest of the World (RoW)

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis, By Key Players, 2014
10.3 Competitive Situation and Trends
10.3.1 Partnerships, Agreements, and Collaborations
10.3.2 Expansions
10.3.3 Acquisitions
10.3.4 New Product Launches

11 Company Profiles (Overview, Financials, Products, & Developments)*
11.1 Merck Millipore
11.2 Thermo Fisher Scientific, Inc.
11.3 Sigma-Aldrich Corporation
11.4 Promega Corporation
11.5 Clontech Laboratories, Inc.
11.6 Agilent Technologies
11.7 Bio-Rad Laboratories
11.8 DNA20., Inc.
11.9 New England Biolabs (NEB)
11.10 Qiagen

12 Appendix
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports 

List of Tables (99 Tables)

Table 1 The Global Market Size, By Host Type, 2013-2020 ($Million)
Table 2 Bacterial Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 3 Bacterial Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 4 North America: Bacterial Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 5 E.Coli Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 6 North America: E.Coli Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 7 Other Bacterial Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 8 North America: Other Bacterial Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 9 Mammalian Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 10 Mammalian Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 11 North America: Mammalian Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 12 CHO Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 13 North America: CHO Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 14 Other Mammalian Vectors Market Size, By Region, 2013-2020 ($Million)
Table 15 North America: Other Mammalian Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 16 Insect Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 17 Insect Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 18 North America: Insect Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 19 Baculovirus Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 20 North America: Baculovirus Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 21 Other Insect Expression Vectors Market Size, By Region, 2013-2020 ($Thousand)
Table 22 North America: Other Insect Expression Vectors Market Size, By Country, 2013-2020 ($Thousand)
Table 23 Yeast Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 24 Yeast Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 25 North America: Yeast Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 26 K. Lactis Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 27 North America: K. Lactis Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 28 P. Pastoris Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 29 North America: P. Pastoris Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 30 S. Cerevisiae Expression Vectors Market Size, By Region, 2013-2020 ($Million)
Table 31 North America: S. Cerevisiae Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 32 Other Yeast Expression Vectors, By Region, 2013-2020 ($Thousand)
Table 33 North America: Market Size for Other Yeast Systems, By Country, 2013-2020 ($Thousand)
Table 34 Other Market Size, By Region, 2013-2020 ($Million)
Table 35 North America: Other Expression Vectors Market Size, By Country, 2013-2020 ($Million)
Table 36 Market Size, By Application, 2013-2020 ($Million)
Table 37 Market Size for Therapeutic Applications, By Region, 2013-2020 ($Million)
Table 38 North America: Market Size for Therapeutic Applications, By Country, 2013-2020 ($Million)
Table 39 Market Size for Research Applications, By Region, 2013-2020 ($Million)
Table 40 North America: Market Size for Research Applications, By Country, 2013-2020 ($Million)
Table 41 Market Size for Industrial Applications, By Region, 2013-2020 ($Million)
Table 42 North America: Market Size for Industrial Applications, By Country, 2013-2020 ($Million)
Table 43 Market Size, By End User, 2013-2020 ($Million)
Table 44 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2013-2020 ($Million)
Table 45 North America: Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2013-2020 ($Million)
Table 46 Market Size for CROS and CMOS, By Region, 2013-2020 ($Million)
Table 47 North America: Market Size for CROS and CMOS, By Country, 2013-2020 ($Million)
Table 48 Market Size for Academic Research Institutes, By Region, 2013-2020 ($Million)
Table 49 North America: Market Size for Academic Research Institutes, By Country, 2013-2020 ($Million)
Table 50 Market Size for Other End Users, By Region, 2013-2020 ($Million)
Table 51 North America: Market Size for Other End Users, By Country, 2013-2020 ($Million)
Table 52 Market Size, By Region, 2013–2020 ($Million)
Table 53 North America: Market Size, By Country, 2013–2020 ($Million)
Table 54 North America: Market Size, By Host Type, 2013–2020 ($Million)
Table 55 North America: Bacterial Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 56 North America: Mammalian Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 57 North America: Yeast Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 58 North America: Insect Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 59 North America: Market Size, By Application, 2013–2020 ($Million)
Table 60 North America: Market Size, End User, 2013–2020 ($Million)
Table 61 U.S.: Market Size, By Host Type, 2013–2020 ($Million)
Table 62 U.S.: Bacterial Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 63 U.S.: Mammalian Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 64 U.S.: Yeast Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 65 U.S.: Insect Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 66 U.S.: Market Size, By Application, 2013–2020 ($Million)
Table 67 U.S.: Market Size, By End User, 2013–2020 ($Million)
Table 68 Canada: Market Size, By Host Type, 2013–2020 ($Million)
Table 69 Canada: Bacterial Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 70 Canada: Mammalian Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 71 Canada: Yeast Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 72 Canada: Insect Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 73 Canada: Market Size, By Application, 2013–2020 ($Million)
Table 74 Canada: Market Size, By End User, 2013–2020 ($Million)
Table 75 Europe: Market Size, By Host Type, 2013–2020 ($Million)
Table 76 Europe: Bacterial Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 77 Europe: Mammalian Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 78 Europe: Yeast Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 79 Europe: Insect Expression Vectors Market Size, By Type, 2013–2020 ($Million)
Table 80 Europe: Market Size, By Application, 2013–2020 ($Million)
Table 81 Europe: Market Size, By End User, 2013-2020 ($Million)
Table 82 Asia: Market Size, By Host Type, 2013-2020 ($Million)
Table 83 Asia: Bacterial Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 84 Asia: Mammalian Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 85 Asia: Yeast Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 86 Asia: Insect Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 87 Asia: Market Size, By Application, 2013-2020 ($Million)
Table 88 Asia: Market Size, By End User, 2013-2020 ($Million)
Table 89 RoW: Market Size, By Host Type, 2013-2020 ($Million)
Table 90 RoW: Bacterial Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 91 RoW: Mammalian Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 92 RoW: Yeast Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 93 RoW: Insect Expression Vectors Market Size, By Type, 2013-2020 ($Million)
Table 94 RoW: Market Size, By Application, 2013-2020 ($Million)
Table 95 RoW: Market Size, By End User, 2013-2020 ($Million)
Table 96 Parterships, Agreements and Collaborations, 2012-2015
Table 97 Expansions, 2012-2015
Table 98 Acquisitions, 2012-2015
Table 99 New Product Launches, 2012-2015

List of Figures (45 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Market Snapshot, By Host Type (2015 vs. 2020)
Figure 7 CROS and CMOS Form the Fastest-Growing End-User Segment
Figure 8 Market, By Application (2015-2020): Therapeutic Applications to Witness Highest Growth
Figure 9 Global Market, By Region: North America Expected to Hold the Largest Share in 2015
Figure 10 Mammalian Expression Vectors Market to Grow at the Highest CAGR From 2015 to 2020
Figure 11 Therapeutic Applications Segment to Witness Highest Growth Rate in the Forecast Period
Figure 12 Pharmaceutical and Biotechnology Companies Command the Largest Share in 2015
Figure 13 Asia to Witness Highest Growth in the Forecast Period
Figure 14 Bacterial, Mammalian, and Insect Expression Vectors : Major Market Segments in 2015
Figure 15 Market Segmentation: By Host Type
Figure 16 Market Segmentation: By Application
Figure 17 Market Segmentation: By End User
Figure 18 Market Segmentation: By Region
Figure 19 Increase in Demand of Protein-Based Drugs to Propel the Market Growth
Figure 20 Mammalian Expression Vectors to Witness Significant Growth in the Forecast Period
Figure 21 Bacterial Expression Vectors to Dominate Expression Vectors Market in 2015
Figure 22 K. Lactis Expression Vectors to Witness Highest Growth
Figure 23 Therapeutic Applications: Fastest-Growing Application Segment
Figure 24 Therapeutic Applications: Asia to Show Highest Growth
Figure 25 End-User Base: Market
Figure 26 CROS and CMOS, A High-Growth End-User Segment in the Market
Figure 27 Asia- an Attractive Destination for All Applications
Figure 28 North America Holds the Largest Share of Global Market (2015)
Figure 29 European Market Snapshot
Figure 30 Asian Market to Grow at Highest CAGR
Figure 31 RoW Market Snapshot
Figure 32 Major Players Adopted Inorganic Growth Strategies for Development
Figure 33 Global Market Share Analysis, By Key Player, 2014.
Figure 34 Market Evolution Framework: Partnerships, Agreements and Collaborations and Expansions Fuelled the Market Growth
Figure 35 Battle for Market Share: Partnerships, Agreements and Collaborations Were the Key Strategies
Figure 36 Merck Millipore: Company Snapshot
Figure 37 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 38 Sigma-Aldrich Corporation: Company Snapshot
Figure 39 Promega Corporation: Company Snapshot
Figure 40 Takara Bio, Inc.: Company Snapshot
Figure 41 Agilent Technologies: Company Snapshot
Figure 42 Bio-Rad Laboratories: Company Snapshot
Figure 43 DNA2.0, Inc.: Company Snapshot
Figure 44 New England Biolabs: Company Snapshot
Figure 45 Qiagen: Company Snapshot

【レポートのキーワード】

発現ベクター、細菌発現ベクター、哺乳類発現ベクター、昆虫発現ベクター、酵母発現ベクター、発現ベクター用途、遺伝子、治療用発現ベクター、産業用発現ベクター、研究用発現ベクター

★調査レポート[発現ベクターの世界市場:細菌発現ベクター、哺乳類発現ベクター、昆虫発現ベクター、酵母発現ベクター] ( Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020 / MAM-BT-3493) 販売に関する免責事項
[発現ベクターの世界市場:細菌発現ベクター、哺乳類発現ベクター、昆虫発現ベクター、酵母発現ベクター] ( Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020 / MAM-BT-3493) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆